2016-2017 Funded Collaborations

International Collaborative Grants

Developing Novel Therapeutic Approaches For High Risk Acute Lymphoblastic Leukemia



Hua E. Yu, Ph.D. Immuno-Oncology City of Hope		Shai Izraeli, M.D. Cancer Research Center Chaim Sheba Medical Center

Characterization Of The Lung Cancer Microbiome And Its Effects On Response To Treatment



Dan Raz, M.D. Surgery City of Hope		Ravid Straussman, M.D., Ph.D. Molecular Cell Biology Weizmann Institute of Science

Spectrum Of Germline P53 And Somatic Genomic Variants In Israeli Breast Cancer Patients



Jeffrey Weitzel, M.D. Population Sciences/Clinical Cancer Genetics City of Hope		Gad Rennert, M.D., Ph.D. Carmel Medical Center, Community Medicine and Epidemiology Clalit National Cancer Control Center

WWOX Loss Activates Aerobic Glycolysis In TNBC



Victoria Seewaldt, M.D. Population Sciences\| City of Hope		Rami Aqeilan, Ph.D. Lautenberg Center for Immunology and Cancer Research Hebrew University/Hadassah Medical School.

Sabbatical

Distribution And Diffusion Of Nanoparticles In Tumoral Tissue



Jacob Berlin, Ph.D. Molecular Medicine City of Hope		Abraham Domb, Ph.D. School of Pharmacy Hebrew University

About the Israel Cancer Research Fund
Israel Cancer Research Fund, a 501(c)(3) organization, is the largest nationwide charitable organization in North America solely devoted to supporting cancer research in Israel. Since its establishment in 1975, ICRF has provided more than 2,200 grants to outstanding cancer researchers whose laboratories are located in all of the leading research institutions, universities and hospitals across Israel. For more information, visit www.icrfonline.org.